Role of cAMP in Cardiomyocyte Viability: Beneficial or Detrimental?

Autor:	Zhang Y; Department of Medicine, Aab Cardiovascular Research Institute (Y.Z., S.C., L.L., S.G., J.J.X., C.Y.)., Chen S; Department of Medicine, Aab Cardiovascular Research Institute (Y.Z., S.C., L.L., S.G., J.J.X., C.Y.)., Luo L; Department of Medicine, Aab Cardiovascular Research Institute (Y.Z., S.C., L.L., S.G., J.J.X., C.Y.).; Department of Biochemistry and Biophysics (L.L.).; Now with Department of Surgery, Stanford University, CA (L.L.)., Greenly S; Department of Medicine, Aab Cardiovascular Research Institute (Y.Z., S.C., L.L., S.G., J.J.X., C.Y.)., Shi H; Department of Clinical and Translational Research (H.S.).; Department of Public Health Sciences, University of Rochester School of Medicine and Dentistry, NY (H.S.)., Xu JJ; Department of Medicine, Aab Cardiovascular Research Institute (Y.Z., S.C., L.L., S.G., J.J.X., C.Y.)., Yan C; Department of Medicine, Aab Cardiovascular Research Institute (Y.Z., S.C., L.L., S.G., J.J.X., C.Y.).
Jazyk:	angličtina
Zdroj:	Circulation research [Circ Res] 2023 Nov 10; Vol. 133 (11), pp. 902-923. Date of Electronic Publication: 2023 Oct 18.
DOI:	10.1161/CIRCRESAHA.123.322652
Abstrakt:	Background: 3', 5'-cyclic AMP (cAMP) regulates numerous cardiac functions. Various hormones and neurotransmitters elevate intracellular cAMP (i[cAMP]) in cardiomyocytes through activating GsPCRs (stimulatory-G-protein-coupled-receptors) and membrane-bound ACs (adenylyl cyclases). Increasing evidence has indicated that stimulating different GsPCRs and ACs exhibits distinct, even opposite effects, on cardiomyocyte viability. However, the underlying mechanisms are not fully understood. Methods: We used molecular and pharmacological approaches to investigate how different GsPCR/cAMP signaling differentially regulate cardiomyocyte viability with in vitro, ex vivo, and in vivo models. Results: For prodeath GsPCRs, we explored β1AR (beta1-adrenergic receptor) and H2R (histamine-H2-receptor). We found that their prodeath effects were similarly dependent on AC5 activation, ATP release to the extracellular space via PANX1 (pannexin-1) channel, and extracellular ATP (e[ATP])-mediated signaling involving in P2X7R (P2X purinoceptor 7) and CaMKII (Ca 2+ /calmodulin-dependent protein kinase II). PANX1 phosphorylation at Serine 206 by cAMP-dependent-PKA (protein-kinase-A) promoted PANX1 activation, which was critical in β1AR- or H2R-induced cardiomyocyte death in vitro and in vivo. β1AR or H2R was localized proximately to PANX1, which permits ATP release. For prosurvival GsPCRs, we explored adenosine-A2-receptor (A2R), CGRPR (calcitonin-gene-related-peptide-receptor), and RXFP1 (relaxin-family peptide-receptor 1). Their prosurvival effects were dependent on AC6 activation, cAMP efflux via MRP4 (multidrug resistance protein 4), extracellular cAMP metabolism to adenosine (e[cAMP]-to-e[ADO]), and e[ADO]-mediated signaling. A2R, CGRPR, or RXFP1 was localized proximately to MRP4, which enables cAMP efflux. Interestingly, exogenously increasing e[cAMP] levels by membrane-impermeable cAMP protected against cardiomyocyte death in vitro and in ex vivo and in vivo mouse hearts with ischemia-reperfusion injuries. Conclusions: Our findings indicate that the functional diversity of different GsPCRs in cardiomyocyte viability could be achieved by their ability to form unique signaling complexes (signalosomes) that determine the fate of cAMP: either stimulate ATP release by activating PKA or directly efflux to be e[cAMP]. Competing Interests: Disclosures None
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu